FDA Releases Draft Guidance on Certificates of Confidentiality

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document outlining its implementation of revised statutory provisions related to Certificates of Confidentiality (CoCs), which aim to protect the privacy of human research participants.